Related Experiment Video
Updated: Apr 5, 2026
07:04
Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
Published on: August 15, 2020
5.9K
[NEURODEGENERATIVE DISEASES; NUTRITIONAL ASPECTS].
Daniel A de Luis1, Olatz Izaola1, Beatriz de la Fuente1
1Medicine School and Unit of Investigation, Center of Investigation of Endocrinology and Nutrition, Hospital Rio Hortega, University of Valladolid, Valladolid.. redactor04@nutricionhospitalaria.com.
Nutricion Hospitalaria
|August 14, 2015
Summary
Nutritional support is crucial for patients with neurodegenerative diseases like Parkinson's, dementia, and ALS. Early evaluation and intervention improve outcomes and prognosis in these complex neurological conditions.
Area of Science:
- Neurology
- Nutritional Science
- Clinical Medicine
Background:
- Neurodegenerative diseases significantly impact consciousness and swallowing, often requiring specialized nutritional support.
- Malnutrition is a major concern in chronic conditions like ALS and dementia, worsening patient prognosis.
Purpose of the Study:
- To review malnutrition risks and treatments in patients with cerebral vascular disease, Parkinson's disease, dementia, and ALS.
- To highlight the importance of nutritional evaluation and intervention in managing neurological diseases.
Main Methods:
- Review of nutritional management strategies for acute (cerebral vascular disease) and chronic (ALS, dementia, Parkinson's) neurological conditions.
- Emphasis on evaluating dysphagia, nutritional status, and appropriate support stages.
- Incorporation of ASPEN guidelines for malnutrition screening in neurological patients.
Main Results:
- Proper nutritional management in acute phases (cerebral vascular disease) improves outcomes and reduces complications.
- Malnutrition significantly worsens prognosis in chronic neurodegenerative diseases.
- Protein intake and distribution are key considerations in advanced Parkinson's disease.
Conclusions:
- Comprehensive nutritional evaluation is essential for patients with neurodegenerative diseases.
- Adequate nutritional support must be integrated into the diagnostic and therapeutic care pathways.
- Proactive nutritional management improves patient outcomes and disease management.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:28Disorders of the Nervous Tissue
3.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.1K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:37Neural Regulation
44.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.9K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K